Reinsurance Group of America

RGA · NYSE

$267.39+$0.59 (+0.22%)TodayMarket closed · Oct 20, 4:05 PM ET

Prev close $266.80

RGA analyst rating

BuyConsensus of 11 analysts over the last 12 months. 73% rate it a buy.

Strong buy0
Buy8
Hold3
Underperform0
Sell0

12-month price target · 11 analysts

Average $266.47 (−0.3% downside)

Low: $149.68
Now: $267.39
High: $317.10

Upgrades and downgrades

The latest rating actions, newest first

RGA analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
JP Morgan	Oct 15, 2026	Maintains	Overweight	$293.00 → $297.00	81%
Wells Fargo	Oct 12, 2026	Maintains	Overweight	$291.00 → $292.00	75%
Barclays	Oct 8, 2026	Maintains	Overweight	$286.00 → $292.00	61%
Barclays	Oct 7, 2026	Maintains	Overweight	$290.00 → $286.00	61%
Morgan Stanley	Aug 24, 2026	Maintains	Equal-Weight	$223.00 → $250.00	59%
Wells Fargo	Aug 19, 2026	Maintains	Overweight	$269.00 → $291.00	75%
JP Morgan	Aug 11, 2026	Maintains	Overweight	$286.00 → $293.00	81%
Barclays	Aug 7, 2026	Maintains	Overweight	$278.00 → $290.00	61%
TD Cowen	Jul 22, 2026	Maintains	Hold	$212.00 → $235.00	54%
JP Morgan	Jul 21, 2026	Maintains	Overweight	$270.00 → $286.00	81%

The case for and against

Updated Jul 31, 2025

Bull case

Reinsurance Group of America Inc. demonstrated a positive financial trajectory in Q4, with book value ex AOCI increasing by 1.1% to $151.31, indicating steady growth in the company's underlying value. The enhancement of RGA's new money yield to 6.04% from 5.68% in Q3, coupled with a higher average portfolio yield of 4.80%, exemplifies the company's robust investment strategy amidst rising yields. Furthermore, the increase in the intermediate operating ROE run rate target to 13% to 15%, alongside a sustained EPS growth target of 8% to 10%, reflects reinforced confidence in the company's long-term profitability potential.

Bear case

Reinsurance Group of America Inc faces a challenging outlook due to headwinds in its Asia Pacific business, which have led to a reduction in the Q1/25 EPS forecast. A projected weak global economic backdrop exacerbates this situation, with expectations of worsening benefit ratios and poor performance from international units contributing to the overall negative outlook. Additionally, higher-than-anticipated Corporate/Other expenses and shortfalls in recent earnings further undermine investor confidence, raising concerns about capital management and operational profitability.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.